TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
SPRO

Spero Therapeutics Inc

Healthcare · Biotechnology

1.20$ -3.3% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Spero Therapeutics Inc (SPRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 53 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SPRO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
107 182 168 150 135 111 78 62 54 69 59 53
102 131 140 122 132 107 75 59 52 67 58 52
94 76 82 64 76 53 49 31 49 40 56 51
94 76 82 64 76 53 49 31 49 40 56 51
3.0 51 54 51 53 52 24 24 2.5 25 0.0 0.0
– 0.0 0.0 – – – – – – – – –
53 75 71 69 70 64 44 29 28 9.9 6.1 8.6
25 37 42 46 49 49 29 15 14 8.9 5.5 8.4
1.7 1.7 1.7 1.7 1.7 1.7 1.8 1.8 1.9 2.0 2.0 2.0
1.1 1.4 3.1 2.7 6.1 7.3 1.8 0.8 1.4 0.7 0.2 0.2
54 107 96 81 66 46 34 33 26 59 53 44
-442 -391 -404 -422 -439 -460 -474 -475 -483 -451 -458 -468
53 53 54 54 54 54 55 56 56 59 57 58

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?